Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines.
about
Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytesThe G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features.GSK1562590, a slowly dissociating urotensin-II receptor antagonist, exhibits prolonged pharmacodynamic activity ex vivoDUX4 differentially regulates transcriptomes of human rhabdomyosarcoma and mouse C2C12 cellsThe peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systemsPotential Clinical Implications of the Urotensin II Receptor Antagonists.Urotensin II in cardiovascular regulation.Role of urotensin II in health and disease.Urotensin-II Ligands: An Overview from Peptide to Nonpeptide StructuresState-dependent calcium mobilization by urotensin-II in cultured human endothelial cells.A novel role of G protein-coupled receptor kinase 5 in urotensin II-stimulated cellular hypertrophy in H9c2UT cells.Palosuran inhibits binding to primate UT receptors in cell membranes but demonstrates differential activity in intact cells and vascular tissues.Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375.The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte activity through common and distinct mechanisms: involvement in cell proliferation.
P2860
Q24642680-795CDF20-85CC-4F27-A2F6-26152AFE8395Q28260943-9FDE2D1F-341C-40FF-8E49-B7C73F037F96Q33599835-A588B514-D64A-4668-B414-CCFE848F50A2Q34233981-52AB53B3-68AE-4681-940F-06596055D308Q34746238-7C0AE075-753A-4625-B9A0-9BF5DCB37C4DQ35100902-9EB767E6-97F5-41A3-865E-3D29A3C92A4CQ35128456-A9B01328-4F63-454C-83D5-D01AFEA90D5BQ37344439-0BEDDD2D-24E8-420C-8446-7BA6D89751E4Q37737495-CC77E9A8-E648-4FE2-BFE0-F7B32F5B448CQ38093584-85B1A1FB-8FB1-4B37-B378-2E5FC3955B57Q38533390-21C83772-88AA-49D0-947F-83641E208B78Q38747134-1AE28301-1704-4006-999B-BAF6CEB33396Q39967100-809E2807-240F-4AA7-8291-004AFB149E30Q40430686-85468983-961F-40E1-8E21-92C8D5DD4BB3Q43146165-B3A1BF6B-F7D0-4AA7-A42F-411FAC43DCFC
P2860
Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Identification and pharmacolog ...... n rhabdomyosarcoma cell lines.
@en
type
label
Identification and pharmacolog ...... n rhabdomyosarcoma cell lines.
@en
prefLabel
Identification and pharmacolog ...... n rhabdomyosarcoma cell lines.
@en
P2093
P2860
P356
P1476
Identification and pharmacolog ...... n rhabdomyosarcoma cell lines.
@en
P2093
Christopher L Herold
Diane Naselsky
Frank Lynch
Jyoti Disa
Nambi V Aiyar
Stephen A Douglas
Zhaohui Ao
P2860
P304
P356
10.1038/SJ.BJP.0705743
P407
P577
2004-06-21T00:00:00Z